We have recently informed about the acquisition of another investor by our portfolio company Bioavlee. The funds obtained allow further development of the technology of identification of microorganisms.
“We set a new quality for laboratory equipment, making detection and identification of microorganisms faster, cheaper, simpler and more accurate” – says Michał Wronecki, CEO of Bioavlee.
What really are the groundbreaking solutions that Bioavlee develops and commercializes? You will find the answer to this question in the weekend edition of Puls Biznesu. We invite you to read!
